Evaluation of the Drug Interactions between Cyclosporin A and Azole Antifungals in Hematopoietic Stem Cell Transplant Recipients
Authors:
- Makoto KuromatsuMKMakoto Kuromatsu
- Takashi KajitaTKTakashi Kajita
- Mai TarunoMTMai Taruno
- Yutaka NishikawaYNYutaka Nishikawa
- Ryousuke YukiyaRYRyousuke Yukiya
- Futoshi IiokaFIFutoshi Iioka
- Yoshitomo MaesakoYMYoshitomo Maesako
- Fumihiko NakamuraFNFumihiko Nakamura
- Hitoshi OhnoHOHitoshi Ohno
- Mutsuaki UedaMUMutsuaki Ueda
- Eitarou NakatsukaENEitarou Nakatsuka
- 1 January 2012
- journal article
- Published by Japanese Society of Pharmaceutical Health Care and Sciences in Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
- Vol. 38 (11) , 688-693
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Itraconazole, a P-Glycoprotein and CYP3A4 Inhibitor, Markedly Raises the Plasma Concentrations and Enhances the Renin-Inhibiting Effect of AliskirenThe Journal of Clinical Pharmacology, 2011
- Intestinal First-Pass Metabolism of CYP3A4 SubstratesDrug Metabolism and Pharmacokinetics, 2008
- Factors Influencing the Magnitude and Clinical Significance of Drug Interactions Between Azole Antifungals and Select ImmunosuppressantsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2006
- Interaction of Common Azole Antifungals with P GlycoproteinAntimicrobial Agents and Chemotherapy, 2002
- Oral antifungals as prophylaxis in haematological malignancyBlood Reviews, 2001
- Clinically Significant Drug Interactions with CyclosporinClinical Pharmacokinetics, 1996
- Differentiation of absorption and first-pass gut and hepatic metabolism in humans: Studies with cyclosporine*Clinical Pharmacology & Therapeutics, 1995
- Pharmacokinetic Drug Interactions with Antimicrobial AgentsClinical Pharmacokinetics, 1993